Realtime | Geld | Brief | Zeit |
---|---|---|---|
7,480 | 7,720 | 13:24 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
05.05. | Nexstim Oyj: Nexstim Plc Business Update Q1 2025 | 68 | GlobeNewswire (Europe) | Press release, Helsinki, 5 May 2025, at 9 AM (EEST)
Nexstim Plc Business Update Q1 2025
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces the key highlights of the Company's business operations... ► Artikel lesen | |
27.02. | Nexstim Oyj: Nexstim Plc's Financial Statements Bulletin 2024 | 170 | GlobeNewswire (Europe) | Company announcement, Helsinki 27 February 2025 at 9 am (EET)
NEXSTIM PLC'S FINANCIAL STATEMENTS BULLETIN 2024
NEXSTIM CONTINUED PROFITABLE GROWTH AND SIGNED SIGNIFICANT PARTNERSHIPS
July-December 2024
The... ► Artikel lesen | |
15.01. | Nexstim Oyj: Insider Information: Nexstim Plc and Sinaptica Therapeutics, Inc. Announce Initiation of Co-Development of the SinaptiStim Precision Neuromodulation System to treat Alzheimer's Disease | 95 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 15 January 2025 at 9 AM (EET)
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") and Sinaptica Therapeutics, Inc. ("Sinaptica"), a clinical-stage company leading the development... ► Artikel lesen | |
29.11.24 | Nexstim Oyj: Inside Information: Nexstim Plc and Brainlab AG initiate collaboration by signing development and distributorship cooperation agreement and agreeing on a maximum of EUR 5,095,000 equity investment into Nexstim | 272 | GlobeNewswire (Europe) | Company Announcement, Helsinki, 29 November 2024 at 9:15 AM (EET)
Inside Information: Nexstim Plc and Brainlab AG initiate collaboration by signing development and distributorship cooperation agreement... ► Artikel lesen | |
16.08.24 | Nexstim Oyj: Nexstim Plc Half-year Report January 1 - June 30, 2024 (unaudited) | 157 | GlobeNewswire (Europe) | Company announcement, Helsinki, August 16, 2024 at 9 am (EEST) NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 - JUNE 30, 2024 (UNAUDITED) NEXSTIM CONTINUED TO GROW AND IMPROVED ITS PROFITABILITY IN THE FIRST... ► Artikel lesen | |
NEXSTIM Aktie jetzt für 0€ handeln | |||||
07.06.24 | Nexstim Oyj: Insider Information: Nexstim Plc Announces Planned Alzheimer's Collaboration with Sinaptica Therapeutics, Inc. | 119 | GlobeNewswire (Europe) | Company announcement, Helsinki, 7 June 2024 at 9 AM (EEST) Insider Information: Nexstim Plc Announces Planned Alzheimer's Collaboration with Sinaptica Therapeutics, Inc. Nexstim Plc (NXTMH:HEX) ("Nexstim"... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports First Quarter 2025 Financial Results and Provides Business Update | SAN DIEGO, May 15, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM), today announced financial results for the first quarter... ► Artikel lesen | |
VERU | 0,448 | -1,54 % | JTC Team, LLC: JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s Enobosarm Taking GLP-1 Weight Loss to Next Level | Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru Watch the "KOL Connect" segment here FRENCHTOWN... ► Artikel lesen | |
FRESENIUS | 42,710 | +2,25 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 49,490 | +1,31 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
UNITEDHEALTH | 250,65 | +2,24 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 51,28 | +0,87 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
KINDLY MD | 13,830 | 0,00 % | David Bailey and Bitcoin-Native Holding Company Nakamoto Announce Merger with KindlyMD to Establish Bitcoin Treasury | Raises $510 Million PIPE and $200 Million in Convertible Notes Marking Largest Capital Raise to Launch a Bitcoin Treasury and the Largest PIPE for Any Public Crypto-Related Transaction
David Bailey... ► Artikel lesen | |
GENEDX | 63,73 | 0,00 % | GeneDx Holdings stock trades higher as upgraded at Jefferies | ||
PROCEPT BIOROBOTICS | 58,15 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
NUTEX HEALTH | 174,34 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
DRAEGERWERK | 63,70 | +2,74 % | EQS-News: Drägerwerk AG & Co. KGaA: Hauptversammlung von Dräger beschließt Dividendenerhöhung - Aufnahme der Vorzugsaktien in den TecDAX | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Hauptversammlung/Dividende
Drägerwerk AG & Co. KGaA: Hauptversammlung von Dräger beschließt Dividendenerhöhung - Aufnahme der... ► Artikel lesen | |
INCANNEX HEALTHCARE | 0,270 | 0,00 % | Incannex Healthcare GAAP EPS of -$0.84, revenue of $0.08M | ||
ALIGNMENT HEALTHCARE | 14,900 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
GERRESHEIMER | 60,90 | -2,09 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Nachhaltigkeit
Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab
12.05.2025... ► Artikel lesen | |
HIMS & HERS HEALTH | 53,02 | +1,18 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month |